These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 441510

  • 21. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E.
    Cancer Res; 1991 Feb 15; 51(4):1086-91. PubMed ID: 1825474
    [Abstract] [Full Text] [Related]

  • 22. Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid.
    Vistica DT, Von Hoff DD, Torain B.
    Cancer Treat Rep; 1981 Feb 15; 65(1-2):157-61. PubMed ID: 7226165
    [Abstract] [Full Text] [Related]

  • 23. Cytostatic activity of naturally isolated isomers of secalonic acids and their chemically rearranged dimers.
    Kurobane I, Iwahashi S, Fukuda A.
    Drugs Exp Clin Res; 1987 Feb 15; 13(6):339-44. PubMed ID: 3652923
    [Abstract] [Full Text] [Related]

  • 24. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H, Uitendaal MP, van der Grint L, Leyva A, Pinedo HM.
    Cancer Res; 1981 Mar 15; 41(3):1193-8. PubMed ID: 6970074
    [Abstract] [Full Text] [Related]

  • 25. Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture.
    Shull RM, Suggs SV, Langley KE, Okino KH, Jacobsen FW, Martin FH.
    Exp Hematol; 1992 Oct 15; 20(9):1118-24. PubMed ID: 1281786
    [Abstract] [Full Text] [Related]

  • 26. Relationships between DNA damage and the survival of murine bone marrow cells irradiated in situ.
    Petrovecki M, Prager A, Terry NH, Murray D.
    Radiat Res; 1994 Jun 15; 138(3):443-50. PubMed ID: 8184020
    [Abstract] [Full Text] [Related]

  • 27. Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids.
    Vistica DT, Schuette BP.
    Mol Pharmacol; 1981 Jan 15; 19(1):92-6. PubMed ID: 7207465
    [No Abstract] [Full Text] [Related]

  • 28. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice.
    Stern AM, Abeles RH, Tashjian AH.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5614-8. PubMed ID: 6498822
    [Abstract] [Full Text] [Related]

  • 29. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK, Konings AW.
    Exp Hematol; 1996 Feb 15; 24(2):246-52. PubMed ID: 8641348
    [Abstract] [Full Text] [Related]

  • 30. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec 15; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 31. Induction of a reversible block in murine CFU-C differentiation by exposure to nitrous oxide.
    Warren DJ, Slørdal L.
    Exp Hematol; 1993 Feb 15; 21(2):345-9. PubMed ID: 8425570
    [Abstract] [Full Text] [Related]

  • 32. Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
    Vistica DT, Ahmad S, Fuller R, Hill J.
    Fed Proc; 1986 Sep 15; 45(10):2447-2450. PubMed ID: 3743787
    [No Abstract] [Full Text] [Related]

  • 33. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
    Yalowich JC, Zucali JR, Gross M, Ross WE.
    Cancer Res; 1985 Oct 15; 45(10):4921-4. PubMed ID: 3861238
    [Abstract] [Full Text] [Related]

  • 34. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
    Brox LW, Gowans B, Belch A.
    Cancer Res; 1980 Apr 15; 40(4):1169-72. PubMed ID: 7357546
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
    Jamieson C, Richter A, Levy JG.
    Exp Hematol; 1993 May 15; 21(5):629-34. PubMed ID: 8513863
    [Abstract] [Full Text] [Related]

  • 36. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE, Singletary SE, Tomasovic B, Spitzer G, Hug V, Drewinko B.
    Int J Cell Cloning; 1984 Nov 15; 2(6):335-40. PubMed ID: 6542929
    [Abstract] [Full Text] [Related]

  • 37. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC, Fang WD.
    J Natl Cancer Inst; 1985 May 15; 74(5):1071-7. PubMed ID: 3858576
    [Abstract] [Full Text] [Related]

  • 38. Prevention of central nervous system toxicity of the antitumor antibiotic acivicin by concomitant infusion of an amino acid mixture.
    Williams MG, Earhart RH, Bailey H, McGovren JP.
    Cancer Res; 1990 Sep 01; 50(17):5475-80. PubMed ID: 2386952
    [Abstract] [Full Text] [Related]

  • 39. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
    Roboz J, Jiang J, Holland JF, Bekesi JG.
    Cancer Res; 1997 Nov 01; 57(21):4795-802. PubMed ID: 9354441
    [Abstract] [Full Text] [Related]

  • 40. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar 01; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.